BioDelivery Sciences shareholder Elliott reduces stake to 17.5%

By Lisa Kerner

Charlotte, N.C., June 22 - Elliott Associates, LP sold 274,005 shares of BioDelivery Sciences International, Inc. between June 17 and June 19 priced from $6.35 to $6.65 each, according to a schedule 13D/A filed on Monday with the Securities and Exchange Commission.

On June 15 and June 16, Elliott sold 605,000 shares and reported an 18.8% ownership interest, a prior SEC filing said.

The investors beneficially own 3,801,345 shares or 17.5% of the Morrisville, N.C.-based pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.